Drug Database
Back to search

Norway· NO-ID_09FEBF8C-635C-4B03-94EF-8144C1DC01A5

Sabrilex

A vigabatrin product containing vigabatrin, registered in Norway by Sanofi-aventis Norge (3). The same ATC class is registered in 17 of our 19 countries.

ATC N03AG04

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedSabrilexATCN03AG04REGISTER NO.NO-ID_09FEBF8C-635C-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vigabatrinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vigabatrin is registered in 17 of 19 countries.

Countries holding a registration under ATC N03AG04 (vigabatrin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose
Search vigabatrin products by name

Vigabatrin · ATC N03AG04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vigabatrin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $3.20 in Italy to $12.93 in France — a ×4.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Vigabatrin · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • FR France$12.93
  • CH Switzerland$3.45
  • IT Italy$3.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Vigabatrin
Manufacturer
Sanofi-aventis Norge (3)
Country
Norway (NO)
ATC code
N03AG04
ATC class
Vigabatrin
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_09FEBF8C-635C-4B03-94EF-8144C1DC01A5
  • no_varenummer
    539049
    50 x 1
    NOK 431.5
  • gtin
    3582910083801

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

115 interactions on record for vigabatrin.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check vigabatrin against other medicinesHow interaction checks work

Vigabatrin · interactions on record

115 records

  • 31 severe
  • 59 moderate

Most severe, free to view

  • OxyquinolineA01AB07severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vigabatrin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vigabatrin products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Sabril
  • Belgium · Sabril
  • Czechia · Sabril
  • Germany · Sabril, Sabril Beutel
  • Denmark · Sabrilex
  • Spain · Sabrilex, Vigzip
  • Finland · Sabrilex
  • France · Sabril, Vigzip
  • United Kingdom (Northern Ireland) · Sabril, Vigabatrin Zydus Pharmaceuticals Uk
  • Greece · Sabril
  • Hungary · Sabril
  • Ireland · Sabril
  • Iceland · Kigabeq, Sabrilex
  • Italy · Sabril, Vigzip
  • Liechtenstein · Kigabeq
  • Luxembourg · Sabril
  • Netherlands · Sabril, Sabril Filmomhulde Tablet
  • Poland · Sabril
  • Portugal · Sabril
  • Sweden · Sabrilex
  • Slovenia · Sabril
  • Slovakia · Sabril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe339499-c3d3-44f6-ae7f-4fd749fef19a
GET /v1/drugs/fe339499-c3d3-44f6-ae7f-4fd749fef19a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulat til mikstur, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Vigabatrin",
  "merkevare_id": "ID_09FEBF8C-635C-4B03-94EF-8144C1DC01A5",
  "name_form_strength": "Sabrilex granulat til mikst, oppl 500 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about vigabatrin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console